The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation• Stanford’s AI Designed Bacteriophages: Ushering in the Next Phase in IP Strategy for Phage Companies?• Breathing Engineered Bacteria: A New Approach to Treating Lung Disease• Vedanta Biosciences Secures $60 Million in Funding Ahead of Pivotal Phase 3 Data• Gut fungi may hold the key to treating Asthma worldwide•

Category: Oncology & Cancer

Mayo scientists developing at-home swab tests for endometrial, ovarian cancer
Oncology & Cancer

Mayo scientists developing at-home swab tests for endometrial, ovarian cancer

JUL 4, 2024
POSTECH and ImmunoBiome team make strides in microbiome-based cancer therapies
Oncology & Cancer

POSTECH and ImmunoBiome team make strides in microbiome-based cancer therapies

MAY 20, 2024
SNIPR Biome receives funding from CARB-X for advancement of SNIPR001 into clinical trials in haematological cancer patients
Clinical & Manufacturing

SNIPR Biome receives funding from CARB-X for advancement of SNIPR001 into clinical trials in haematological cancer patients

APR 22, 2024
Bacteria subtype linked to growth in up to 50% of human colorectal cancers
Basic & Discovery Research

Bacteria subtype linked to growth in up to 50% of human colorectal cancers

MAR 26, 2024
Researchers Call for Regulation of Direct-to-Consumer Microbiome Tests
Basic & Discovery Research

Researchers Call for Regulation of Direct-to-Consumer Microbiome Tests

MAR 21, 2024
New microbiome insights could help boost immunotherapy for a range of rare cancers
Basic & Discovery Research

New microbiome insights could help boost immunotherapy for a range of rare cancers

MAR 4, 2024
Neobe Therapeutics Raises Over $2m For Synthetic Biology Enabled Tumour Microenvironment Remodelling
Finance

Neobe Therapeutics Raises Over $2m For Synthetic Biology Enabled Tumour Microenvironment Remodelling

MAR 1, 2024
Boehringer Ingelheim acquires bacterial cancer therapy specialist T3 Pharma
Finance

Boehringer Ingelheim acquires bacterial cancer therapy specialist T3 Pharma

NOV 22, 2023
MaaT Pharma Announces First Patient Dosed in Phase 2b Randomized Clinical Trial Evaluating MaaT033 in Patients Receiving Allo-HSCT
Clinical & Manufacturing

MaaT Pharma Announces First Patient Dosed in Phase 2b Randomized Clinical Trial Evaluating MaaT033 in Patients Receiving Allo-HSCT

NOV 7, 2023
Engineered bacteria guide CAR-T cells to poorly infiltrated solid tumors
Genetically Modified Organisms & Synthetic Biology

Engineered bacteria guide CAR-T cells to poorly infiltrated solid tumors

NOV 6, 2023
Scientists and clinicians use AI analysis of the gut microbiome to detect colon cancer
Oncology & Cancer

Scientists and clinicians use AI analysis of the gut microbiome to detect colon cancer

JUN 12, 2023